Inventor · disambiguated record
Valentina Molteni
Also filed as: MOLTENI VALENTINA
39 granted patents·15 pending applications·375 citations·filing 2002–2022
97Inventor score
Top patents by PatentIndex Score
54 records- 0196US9102671B2Compounds and compositions as TRK inhibitorsMOLTENI VALENTINA·Filed 2012·Granted Aug 11, 2015·80 cites·19 claims
- 0296US8338417B2Compounds and compositions as c-kit and PDGFR kinase inhibitorsLI XIAOLIN·Filed 2008·Granted Dec 25, 2012·86 cites·8 claims
- 0393US8637516B2Compounds and compositions as TRK inhibitorsFAN YI·Filed 2011·Granted Jan 28, 2014·82 cites·29 claims
- 0490US8268850B2Pyrimidine derivatives and compositions as C-kit and PDGFR kinase inhibitorsLI XIAOLIN·Filed 2008·Granted Sep 18, 2012·16 cites·8 claims
- 0589US8569283B2Compounds and compositions as c-Kit kinase inhibitorsMOLTENI VALENTINA·Filed 2012·Granted Oct 29, 2013·12 cites·26 claims
- 0689US8288540B22-heteroarylamino-pyrimidine derivatives as kinase inhibitorsCHIANELLI DONATELLA·Filed 2008·Granted Oct 16, 2012·20 cites·15 claims
- 0789US7678792B2Compositions and methods for modulating c-kit and PDGFR receptorsIRM LLC·Filed 2007·Granted Mar 16, 2010·13 cites·17 claims
- 0886US10077240B2Compositions and methods for modulating farnesoid X receptorsNOVARTIS AG·Filed 2017·Granted Sep 18, 2018·4 cites·15 claims
- 0982US8293757B25-(4-(haloalkoxy)phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitorsMOLTENI VALENTINA·Filed 2008·Granted Oct 23, 2012·6 cites·7 claims
- 1081US9199981B2Compounds and compositions as C-kit kinase inhibitorsYEH VINCE·Filed 2012·Granted Dec 1, 2015·9 cites·26 claims
- 1181US7592349B2Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptorsIRM LLC·Filed 2007·Granted Sep 22, 2009·3 cites·14 claims
- 1281US7563894B2Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptorsIRM LLC·Filed 2007·Granted Jul 21, 2009·3 cites·10 claims
- 1381US7253164B2Bicyclic compounds and compositions as PDF inhibitorsIRM LLC·Filed 2004·Granted Aug 7, 2007·11 cites·6 claims
- 1479US9682939B2Compositions and methods for modulating farnesoid X receptorsCHIANELLI DONATELLA·Filed 2014·Granted Jun 20, 2017·3 cites·27 claims
- 1578US9186361B2Compounds and compositions for the treatment of parasitic diseasesCHATTERJEE ARNAB KUMAR·Filed 2014·Granted Nov 17, 2015·3 cites·17 claims
- 1678US9023839B2Compounds and compositions as c-kit kinase inhibitorsMOLTENI VALENTINA·Filed 2014·Granted May 5, 2015·3 cites·24 claims
- 1778US7514447B2Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptorsIRM LLC·Filed 2006·Granted Apr 7, 2009·2 cites·6 claims
- 1875US7638523B2Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptorsIRM LLC·Filed 2007·Granted Dec 29, 2009·1 cites·14 claims
- 1974US8106068B2Compositions and methods for modulating c-kit and PDGFR receptorsLIU ZUOSHENG·Filed 2009·Granted Jan 31, 2012·3 cites·6 claims
- 2073US9303034B2Compounds and compositions for the treatment of parasitic diseasesBIGGART AGNES·Filed 2014·Granted Apr 5, 2016·2 cites·25 claims
- 2173US7276526B2Substituted thiazoles and oxazoles as corticotropin releasing hormone ligandsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Oct 2, 2007·6 cites·8 claims
- 2273US2021369716A1Compounds and compositions for the treatment of parasitic diseasesNOVARTIS AG·Filed 2021·Application pending·0 cites
- 2372US10683271B2Compositions and methods for modulating farnesoid X receptorsNOVARTIS AG·Filed 2018·Granted Jun 16, 2020·0 cites·15 claims
- 2472US9296754B2Compounds and compositions for the treatment of parasitic diseasesLIANG FANG·Filed 2014·Granted Mar 29, 2016·2 cites·17 claims
- 2572US2021253534A1Compositions and methods for modulating farnesoid x receptorsNOVARTIS AG·Filed 2021·Application pending·0 cites
- 2671US11021446B2Compositions and methods for modulating farnesoid X receptorsNOVARTIS AG·Filed 2020·Granted Jun 1, 2021·0 cites·13 claims
- 2768US11384078B25,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseasesNOVARTIS AG·Filed 2018·Granted Jul 12, 2022·1 cites·20 claims
- 2867US11123348B2Compounds and compositions for the treatment of parasitic diseasesNOVARTIS AG·Filed 2020·Granted Sep 21, 2021·0 cites·5 claims
- 2967US2009264649A1Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptorsIRM LLC·Filed 2009·Application pending·0 cites
- 3066US10596175B2Compounds and compositions for the treatment of parasitic diseasesNOVARTIS AG·Filed 2018·Granted Mar 24, 2020·0 cites·5 claims
- 3166US9233961B2Compounds and compositions for the treatment of parasitic diseasesCHATTERJEE ARNAB KUMAR·Filed 2014·Granted Jan 12, 2016·1 cites·20 claims
- 3265US7297708B2Heteroaromatic substituted cyclopropane as corticotropin releasing hormone ligandsBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Nov 20, 2007·3 cites·8 claims
- 3363US7579363B2Bicyclic compounds and compositions as PDF inhibitorsIRM LLC·Filed 2007·Granted Aug 25, 2009·0 cites·1 claims
- 3462US2022340573A11,2,4-oxadiazole derivatives as liver x receptor agonistsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 3560US10085989B2Compounds and compositions for the treatment of parasitic diseasesNOVARTIS AG·Filed 2017·Granted Oct 2, 2018·0 cites·15 claims
- 3660US2022324863A15,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseasesNOVARTIS AG·Filed 2022·Application pending·0 cites
- 3759US11427586B21,2,4-oxadiazole derivatives as liver X receptor agonistsNOVARTIS AG·Filed 2020·Granted Aug 30, 2022·0 cites·21 claims
- 3855US2013345220A1Compounds and compositions as lxr modulatorsMOLTENI VALENTINA·Filed 2013·Application pending·0 cites
- 3955US2024238305A1Formulations of 3-((3-(4-(2-(isobutylsulfonyl)phenoxy)-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-5-yl)methyl)-5,5-dimethyl-1-(2-morpholinoethyl)imidazolidine-2,4-dioneNOVARTIS AG·Filed 2022·Application pending·0 cites
- 4053US9700559B2Compounds and compositions for the treatment of parasitic diseasesBIGGART AGNES·Filed 2016·Granted Jul 11, 2017·0 cites·10 claims
- 4153US8569345B2Compounds and compositions as LXR modulatorsMOLTENI VALENTINA·Filed 2012·Granted Oct 29, 2013·0 cites·6 claims
- 4253US8158662B2Compounds and compositions as LXR modulatorsMOLTENI VALENTINA·Filed 2005·Granted Apr 17, 2012·0 cites·6 claims
- 4351US9751876B2Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertensionNOVARTIS AG·Filed 2014·Granted Sep 5, 2017·0 cites·18 claims
- 4451US8278452B2Heterocyclic compounds and compositions as c-kit and PDGFR kinase inhibitorsCHIANELLI DONATELLA·Filed 2009·Granted Oct 2, 2012·0 cites·14 claims
- 4550US7846949B2Compounds and compositions as LXR modulatorsIRM LLC·Filed 2005·Granted Dec 7, 2010·0 cites·3 claims
- 4649US2010184791A1Compounds and compositions as c-kit and pdgfr kinase inhibitorsIRM LLC·Filed 2008·Application pending·0 cites
- 4747US2010048539A1Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2007·Application pending·0 cites
- 4843US2009062260A1Compounds and compositions as lxr modulatorsIRM LLC·Filed 2006·Application pending·0 cites
- 4943US2009137610A1Spiro imidozole derivatives as ppar modulatorsIRM LLC·Filed 2007·Application pending·0 cites
- 5041US2015051206A1Compounds and compositions as c-kit kinase inhibitorsLOREN JON·Filed 2012·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →